Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4A | O75164 | 2/20 | 0.54 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.54 |
| ▸ | CHKA | P35790 | 10/20 | 0.40 |
| ▸ | ACHE | P22303 | 3/20 | 0.40 |
| ▸ | BCHE | P06276 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9004476 | 0.81 | TRPA1 (0.48) | KDM4EALDH1A1HPGDCYP2C19RAB9A | |
| SCHEMBL9004477 | 0.81 | TRPA1 (0.48) | KDM4EALDH1A1HPGDCYP2C19RAB9A | |
| SCHEMBL25459981 | 0.79 | CHKA (0.53) | CHKAACHEBCHEKDM4EALDH1A1 | |
| SCHEMBL15835871 | 0.78 | CHKA (0.56) | CHKAACHEBCHEKDM4EALDH1A1 | |
| SCHEMBL15835877 | 0.78 | CHKA (0.56) | CHKAACHEBCHEKDM4EALDH1A1 | |
| SCHEMBL14984173 | 0.77 | KDM4A (0.85) | KDM4AKDM2ACHKAALDH1A1 | |
| SCHEMBL26497813 | 0.75 | ACHE (0.53) | CHKAACHEBCHEKDM4EALDH1A1 | |
| SCHEMBL27811786 | 0.75 | KDM4A (0.49) | KDM4AKDM2ACHKAACHEKDM4E | |
| SCHEMBL14077508 | 0.74 | KDM4A (0.51) | KDM4AKDM2ACHKAACHEBCHE | |
| SCHEMBL889824 | 0.74 | KDM4A (0.51) | KDM4AKDM2ACHKAACHEBCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230322781-A1 | RING-IN-RING COMPLEXES EXHIBITING TUNABLE MULTICOLOR PHOTOLUMINESCENCE | NORTHWESTERN UNIVERSITY | 2023-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230322781-A1 | RING-IN-RING COMPLEXES EXHIBITING TUNABLE MULTICOLOR PHOTOLUMINESCENCE | PPIE, CYCS, PPIC | KDM4A 1189/4885KDM2A 2568/4885CHKA 3635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.